Immunosenescence
23
8
9
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 23 trials
100.0%
+13.4% vs benchmark
9%
2 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (23)
Precision Microbiota Interventions for Senoreduction Trial
Influenza Vaccine Immunogenicity in Repeatedly Vaccinated Older Adults
Immune Aging and Advanced Therapy Outcomes in Older Adults With IBD
Exploratory Study on Infection and Immunosenescence Based on an Elderly Clinical Cohort
COVID-19 Serology and Immunosenescence
Research Project on the Interaction Between Immune Function and Infectious Diseases in Older Adults and the Development of Prevention and Control Strategies
Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial
Interferon Reference for Older People - REFIPA Study
The Impact of Aerobic Exercise Program on Immunosenescence Institutionalized Older Adults
Effect of Oral Supplement on Influenza Vaccine Long-term Response
VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle
Biobank and Brain Health in Bordeaux.
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
The Immu-KNEE-ty Study
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Pyridostigmine as Immunomodulator in People Living With HIV
Fasting-mimicking Diet and Immunosenescence
Effect of Milk Protein and Prebiotics in Combination With Vitamin D on Innate Immunity in Elderly People